4//SEC Filing
MARTIN J TYLER 4
Accession 0001181431-12-008916
CIK 0001029142other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:03 PM ET
Size
12.3 KB
Accession
0001181431-12-008916
Insider Transaction Report
Form 4
MARTIN J TYLER
VP Clinical Development & CMO
Transactions
- Award
Common shares
2012-02-13$0.58/sh+150,000$87,000→ 150,000 total - Award
Common shares
2012-02-13$1.72/sh+32,848$56,499→ 182,848 total - Exercise/Conversion
Option (Right to Buy)
2012-02-13−75,000→ 225,000 totalExercise: $0.58From: 2010-02-27Exp: 2019-02-26→ Common Stock (75,000 underlying) - Exercise/Conversion
Options (Right to Buy)
2012-02-13−75,000→ 150,000 totalExercise: $0.58From: 2011-02-27Exp: 2019-02-26→ Common Stock (75,000 underlying) - Exercise/Conversion
Options (Right to Buy)
2012-02-13−32,848→ 484,396 totalExercise: $1.72From: 2011-08-25Exp: 2020-08-24→ Common Stock (32,848 underlying)
Footnotes (2)
- [F1]Not applicable.
- [F2]On February 13, 2012, Dr. Martin exercised certain of his outstanding options for cash. No shares were sold in the market in connection with this exercise.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001234388
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:03 PM ET
- Size
- 12.3 KB